Biotech · Private company
Harvard Apparatus Regenerative Technology, Inc.
Track this companyFree. Adds Harvard Apparatus Regenerative Technology, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- CEI Extra-Thoracic Subdermal Surgical Implantation - Cellspan™ Esophageal Implant-Adult (CEI) in patients that have had a previous partial esophagectomyPhase 1 · Esophageal DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- CEI Thoracic Surgical Implantation-Cellspan™ Esophageal Implant-Adult (CEI) in patients requiring a full reconstruction of the esophagusPhase 1 · Esophageal DiseasesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal ReplacementPHASE1 · RECRUITING · started Jul 13, 2023ClinicalTrials.gov NCT05877300 · fetched Nov 12, 2026